PN

Philippe Nore

North America, California, United States, Palo Alto

Description

Philippe Nore is the Vice President for MRD Pharma at Adaptive Biotechnologies. He attended The Wharton School.

Investor Profile

Philippe Nore has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Grant rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Grant (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Philippe Nore frequently co-invest with?

MI
North America, California, United States, Los Angeles
Co-Investments: 1
Scientific Health Development Partners
North America, Texas, United States, Dallas
Co-Investments: 1
MIT Alumni Angels of Northern California
North America, Massachusetts, United States, Cambridge
Co-Investments: 1

What are some of recent deals done by Philippe Nore?

MiNDERA Corporation

South San Francisco, California, United States

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases.

BiotechnologyHealth CareMedicalProduct Research
GrantSep 30, 2015
Amount Raised: $1,100,000